GlassScriptPhysician profile
Bethany M Alabek
NPI 1801149158
$15,194.78
in general payments reported to CMS, 2019-2025
11 companies · $3,913 in 2025
The $3,913 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,913 · 2023: $3,407 · 2024: $4,963 · 2025: $3,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $1,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,129.22 |
| Travel and Lodging | $1,152.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,492.59 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Abbott Laboratories | $4,434.82 | 2021-2025 | Proclaim, Penta |
| Stryker Corporation | $3,590.67 | 2021-2025 | Everest Spinal System, Yukon Oct Spinal System, Cascadia Interbody System |
| Medical Device Business Services, INC. | $1,351.20 | 2024 | Stratafix |
| Vb Spine LLC | $727.68 | 2025 | Everest Spinal System, Mesa Spinal System, Vesuvius |
| Ethicon US, LLC | $325.53 | 2021-2025 | Stratafix, Ethicon, Dermabond Prineo |
| Si-Bone, INC. | $157.19 | 2023 | |
| Becton, Dickinson and Company | $47.33 | 2025 | Surgiphor |
| Nevro Corp. | $34.32 | 2023 | Senza |
| Grt US Holding, INC. | $21.32 | 2021 | |
| Smith+Nephew, INC. | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Alabek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.